Esperion Therapeutics
ESPR
#6604
Rank
A$1.17 B
Marketcap
A$4.54
Share price
0.00%
Change (1 day)
158.90%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of March 2026 : A$0.66 Billion

According to Esperion Therapeutics's latest financial reports the company's total assets are A$0.66 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$0.69 B25.83%
2024-12-31A$0.55 B83%
2023-12-31A$0.30 B-17.09%
2022-12-31A$0.36 B-30.78%
2021-12-31A$0.52 B14.57%
2020-12-31A$0.45 B49.99%
2019-12-31A$0.30 B50.42%
2018-12-31A$0.20 B-42.78%
2017-12-31A$0.35 B4.61%
2016-12-31A$0.34 B-16.16%
2015-12-31A$0.40 B131.76%
2014-12-31A$0.17 B99.45%
2013-12-31A$87.77 M1147.41%
2012-12-31A$7.03 M231%
2011-12-31A$2.12 M
2002-12-31A$91.24 M-40.56%
2001-12-31A$0.15 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
A$296.56 B 44,787.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$58.37 B 8,735.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$1.85 B 180.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.38 B-41.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$1.35 B 105.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$12.27 B 1,757.40%๐Ÿ‡บ๐Ÿ‡ธ USA